搜尋結果
1 天前 · COVID-19 vaccine maker BioNTech won up to $145 million in funding from a global coalition against infectious diseases to build a production network in African countries for messenger-RNA based shots.
1 天前 · BioNTech's Kigali facility, inaugurated in December 2023, is based on the company's BioNTainers - modular manufacturing units capable of producing various mRNA-based vaccines.
1 天前 · BioNTech on Wednesday expanded its strategic partnership with the Coalition for Epidemic Preparedness Innovations, securing $145 million in funding to boost its mRNA vaccine footprint in Africa. The German biotech will use the funding to enhance the mRNA vaccine research and development capacity of its facility in Kigali, Rwanda.
2 天前 · On September 11, 2023, the updated Moderna and Pfizer–BioNTech mRNA vaccines (i.e., 2023–2024 formulas) against coronavirus disease 2019 (Covid-19) containing the severe acute respiratory ...
2 天前 · CEPI is committing up to US $145 million 1 to support BioNTech to establish mRNA vaccine R&D, clinical and commercial-scale manufacturing capabilities at the Company’s facility in Kigali, Rwanda. These capabilities will contribute to efforts to better prepare for potential future epidemic and pandemic threats in Africa.
2 天前 · BioNTech (BNTX) and MediLink are not strangers. In October 2023, the German biotech paid $1.1B for global rights for the latter's HER3 antibody drug conjugate candidate BNT326/YL202. More on BioNTech
4 天前 · 转发：0. 回复：0. 喜欢：0. Armstrong. 2024年5月27日，宜联生物宣布与 BioNTech 达成ADC技术授权合作，BioNTech将获得一项利用TMALIN® ADC技术平台开发针对限定的某几个前沿创新靶点ADC产品的独家选择权及相应全球独家许可。. BioNTech支付2500万美元预付款，最高18亿美元的 ...
